BACKGROUND:

Urolithiasis and metabolic syndrome are considered a worldwide pandemic, with important health system repercussions. Mexico has a high incidence of both pathologies. Identifying the predisposing factors of urolithiasis will prevent recurrence, complications, and surgical treatments.

OBJECTIVE:

To establish the prevalence of metabolic syndrome and evaluate the modifications in urolithiasis pathophysiology.

MATERIALS AND METHODS:

A non-randomized cross-sectional study was conducted on patients seen at the Hospital General de México Dr. Eduardo Liceaga, diagnosed with urolithiasis within the time frame of March to December 2016. Study variables: anthropometric measurements, blood pressure readings, and fasting glucose levels and lipid profiles.

RESULTS:

Eighty-four patients, 32 men and 52 women, were enrolled in the study. Their mean age was 47.3 ± 14.1 years. A total of 52% of the cases of urolithiasis corresponded to women. Metabolic syndrome was diagnosed in 58 of the study patients, 29% of whom were men and 71% women, representing a woman:man prevalence ratio of 3:1.

CONCLUSIONS:

Urolithiasis should not be considered an isolated entity, but rather understood in a multifactorial context and as a systemic disease.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )